HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PCR-based screening for the most prevalent alpha 1 antitrypsin deficiency mutations (PI S, Z, and Mmalton) in COPD patients from Eastern Tunisia.

Abstract
It is generally agreed that the protease inhibitor (PI) alleles PI*S (Val264Glu) and PI*Z (Lys342Glu) are the most common alpha 1 antitrypsin deficiency variants worldwide, but the PI*Mmalton allele (ΔPhe52) prevails over these variants in some Mediterranean regions. In eastern Tunisia (Mahdia), we screened 100 subjects with chronic obstructive pulmonary disease for these variants. The PI*S and PI*Z alleles were genotyped by the previously described SexAI/Hpγ99I RFLP-PCR. We provide here a new method for PI*Mmalton genotyping using mismatched RFLP-PCR. These methods are suitable for routine clinical application and can easily be reproduced by several laboratories, since they do not require extensive optimization, unlike the previously described bidirectional allele-specific amplification PCR for PI*Mmalton genotyping. Our results were in agreement with previous reports from central Tunisia (Kairouan), suggesting that the PI*Mmalton mutation is the most frequent alpha 1 antitrypsin deficiency-related mutation in Tunisia.
AuthorsSabri Denden, Ramzi Lakhdar, Nadia Boudawara Keskes, Mohamed Hedi Hamdaoui, Jemni Ben Chibani, Amel Haj Khelil
JournalBiochemical genetics (Biochem Genet) Vol. 51 Issue 9-10 Pg. 677-85 (Oct 2013) ISSN: 1573-4927 [Electronic] United States
PMID23666394 (Publication Type: Journal Article)
Chemical References
  • alpha 1-Antitrypsin
Topics
  • Alleles
  • Genetic Variation
  • Genotyping Techniques
  • Humans
  • Mutation
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length
  • Prevalence
  • Pulmonary Disease, Chronic Obstructive (genetics)
  • Tunisia
  • alpha 1-Antitrypsin (genetics)
  • alpha 1-Antitrypsin Deficiency (diagnosis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: